ASHWIN GOLLERKERI,KAREN VELASTEGUI,RAFFAELE BAFFA,JAYMES SCOT HOLLAND
申请号：
US15573303
公开号：
US20180099054A1
申请日:
2016.05.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides for dosing regimens for the treatment of patients with cancer and/or an EFNA4-associated disorder with an anti-EFNA4 antibody-drug conjugate (ADC). The present invention further provides for methods for the treatment of patients with cancer and/or an EFNA4-associated disorder in which an anti-EFNA4 ADC is administered intravenously weekly (QW) or every 3 weeks (Q3W).
